[1]
Kamrun Naher and Akterun Nahar, “Intrauterine Misoprostol Versus Intravenous Oxytocin for the Prevention of Primary Postpartum Hemorrhage During Cesarean Section: A One-Year Randomized Controlled Trial”, Eastern Med. Coll. J., vol. 10, no. 2, pp. 111–115, Jan. 2026.